FDA Approved: UNITUXIN — Original Application (United Therapeutics Corporation)

View source ↗

Summary

FDA approved Unituxin (dinutuximab) from United Therapeutics via an original application for treating pediatric patients with high-risk neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• UNITUXIN (dinutuximab)

Snippet

ORIG AP for UNITUXIN (DINUTUXIMAB)